Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
![]() |
Evolocumab treatment in patients with HIV and hypercholesterolemia/mixed dyslipidemia BEIJERINCK study design and baseline characteristicsFranck Boccara Princy Kumar; Bruno Caramelli; Alexandra Calmy; J. Antonio G Lopez; Sarah Bray; Marcoli Cyrille; Robert S RosensonAmerican heart journal v. 220, p. 203-212, 2020New York 2020Acesso online. A biblioteca também possui exemplares impressos. |
2 |
Material Type: Artigo
|
![]() |
Long-term effects of evolocumab in participants with HIV and dyslipidemia results from the open-label extension periodFranck Boccara Bruno Caramelli; Alexandra Calmy; Princy Kumar; J. Antonio G Lopez; Sarah Bray; Marcoli Cyrille; Robert S RosensonAids v. 36, n. 5, p. 675-682, 2022Philadelphia 2022Acesso online. A biblioteca também possui exemplares impressos. |
3 |
Material Type: Artigo
|
![]() |
Evolocumab in HIV-Infected Patients With Dyslipidemia Primary Results of the Randomized, Double-Blind BEIJERINCK StudyFranck Boccara Princy N Kumar; Bruno Caramelli; Alexandra Calmy; J. Antonio G Lopez; Sarah Bray; Marcoli Cyrille; Robert S RosensonJournal of the american college of cardiology v. 75, n. 20, p. 2570-2584, 2020New York 2020Acesso online. A biblioteca também possui exemplares impressos. |
4 |
Material Type: Artigo
|
![]() |
Phase 3 Study of Ibalizumab for Multidrug-Resistant HIV-1Emu, Brinda ; Fessel, Jeffrey ; Schrader, Shannon ; Kumar, Princy ; Richmond, Gary ; Win, Sandra ; Weinheimer, Steven ; Marsolais, Christian ; Lewis, StanleyThe New England journal of medicine, 2018-08, Vol.379 (7), p.645-654 [Periódico revisado por pares]United States: Massachusetts Medical SocietyTexto completo disponível |
5 |
Material Type: Artigo
|
![]() |
Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection in Patients at Increased Risk for RecurrenceGerding, Dale N ; Kelly, Ciaran P ; Rahav, Galia ; Lee, Christine ; Dubberke, Erik R ; Kumar, Princy N ; Yacyshyn, Bruce ; Kao, Dina ; Eves, Karen ; Ellison, Misoo C ; Hanson, Mary E ; Guris, Dalya ; Dorr, Mary BethClinical infectious diseases, 2018-08, Vol.67 (5), p.649-656 [Periódico revisado por pares]US: Oxford University PressTexto completo disponível |
6 |
Material Type: Artigo
|
![]() |
Weight gain following switch to integrase inhibitors from non-nucleoside reverse transcriptase or protease inhibitors in people living with HIV in the United States: analyses of electronic medical records and prescription claimsTse, Jenny ; Prajapati, Girish ; Zhao, Xiaohui ; Near, Aimee M ; Kumar, Princy NCurrent medical research and opinion, 2023-09, Vol.39 (9), p.1-1246 [Periódico revisado por pares]EnglandTexto completo disponível |
7 |
Material Type: Artigo
|
![]() |
Weight gain after antiretroviral therapy initiation in people living with HIV in the United States: analyses of electronic medical records and prescription claimsZhao, Xiaohui ; Prajapati, Girish ; Tse, Jenny ; Near, Aimee M. ; Kumar, Princy N.Current medical research and opinion, 2023-07, Vol.39 (7), p.997-1006 [Periódico revisado por pares]England: Taylor & FrancisTexto completo disponível |
8 |
Material Type: Artigo
|
![]() |
Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trialsEron, Joseph J, Prof ; Young, Benjamin, MD ; Cooper, David A, Prof ; Youle, Michael, MD ; DeJesus, Edwin, MD ; Andrade-Villanueva, Jaime, MD ; Workman, Cassy, MD ; Zajdenverg, Roberto, MD ; Fätkenheuer, Gerd, Prof ; Berger, Daniel S, MD ; Kumar, Princy N, MD ; Rodgers, Anthony J, MS ; Shaughnessy, Melissa A, MS ; Walker, Monica L, BS ; Barnard, Richard JO, PhD ; Miller, Michael D, PhD ; DiNubile, Mark J, MD ; Nguyen, Bach-Yen, MD ; Leavitt, Randi, MD ; Xu, Xia, PhD ; Sklar, Peter, DrThe Lancet (British edition), 2010-01, Vol.375 (9712), p.396-407 [Periódico revisado por pares]Kidlington: Elsevier LtdTexto completo disponível |
9 |
Material Type: Artigo
|
![]() |
Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trialsEron, Joseph J, Prof ; Cooper, David A, Prof ; Steigbigel, Roy T, Prof ; Clotet, Bonaventura, MD ; Gatell, Jose M, Prof ; Kumar, Princy N, Prof ; Rockstroh, Jurgen K, Prof ; Schechter, Mauro, Prof ; Markowitz, Martin, Prof ; Yeni, Patrick, MD ; Loutfy, Mona R, MD ; Lazzarin, Adriano, Prof ; Lennox, Jeffrey L, Prof ; Strohmaier, Kim M, BS ; Wan, Hong, MS ; Barnard, Richard JO, PhD ; Nguyen, Bach-Yen T, MD ; Teppler, Hedy, MDThe Lancet infectious diseases, 2013-07, Vol.13 (7), p.587-596 [Periódico revisado por pares]London: Elsevier LtdTexto completo disponível |
10 |
Material Type: Artigo
|
![]() |
A Multicenter Randomized Controlled Trial of Intensive Group Therapy for Tobacco Treatment in HIV-Infected Cigarette SmokersStanton, Cassandra A ; Kumar, Princy N ; Moadel, Alyson B ; Cunningham, Chinazo O ; Schechter, Clyde B ; Kim, Ryung S ; Shuter, JonathanJournal of acquired immune deficiency syndromes (1999), 2020-04, Vol.83 (4), p.405-414 [Periódico revisado por pares]United States: Copyright Wolters Kluwer Health, Inc. All rights reservedTexto completo disponível |